- Harris, N.L., Jaffe, E.S. and Diebold. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia. November 1997", J. Clin. Oncol. 17, 3835-3849.
- Kyle, R.A. and Garton, J.P. (1987) "The spectrum of IgM monoclonal gammopathy in 430 cases", Mayo Clin. Proc. 62, 719-731.
- Dimopoulos, M.A., Panayiotidis, P. and Moulopoulos, L.A. (2000) "Waldenstrom's macroglobulinemia: clinical features, complications and management", J. Clin. Oncol. 18, 214-226.
- Kyle, R.A., Greipp, P.R. and Gertz, M.A. (2000) "Waldenstrom's macroglobulinemia: a prospective study comparing daily with intermittent oral chlorambucil", Br. J. Haematol. 108, 737-742.
- Dimopoulos, M.A., Kantarjian, H. and Weber, D. (1994) "Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine", J. Clin. Oncol. 12, 2694-2698.
- Dimopoulos, M.A., O'Brien, S. and Kantargian, H. (1993) "Fludarabine therapy in Waldenstrom's macroglobulinemia", Am. J. Med. 95, 49-52.
- Foran, J.M., Rohatiner, A.Z.S. and Coiffier, B. (1999) "Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldnstrom's macroglobulinemia, and mantle-cell lymphoma", J. Clin. Oncol. 17, 546-553.
- Dhodapkar, M.V., Jacobson, J.L. and Gertz, M.A. (2001) "Prognostic factors and response to fludarabine therapy in patients with Waldenstrom's macroglobulinemia: results of United States intergroup trial", Blood 98, 41-48.
- Leblond, V., Ben-Othman, T. and Deconinck, E. (1998) "Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: a report of 71 cases", J. Clin. Oncol. 16, 2060-2064.
- Leblond, V., Levy, V. and Maloisel, F. (2001) "Multicenter randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom's macroglobulinemia in first relapse or with primary refractory disease", Blood 98, 2640-2644.
- Losses, I.S., Paltiel, O. and Polliack, A. (1999) "Salvage chemotherapy using a combination of fludarabine and cyclopbosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphoma", Leuk. Lymphoma 33, 155-160.
- Hochster, H.S., Oken, M.M., Winter, J.N., Gordon, L.I., Raphael, B.G., Bennet, J.M. and Cassileth, P.A. (2000) "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results an long-term follow-up a report from the Eastern Cooperative Oncology Group", J. Clin. Oncol. 18, 987-994.
- Flinn, I.W., Byrd, J.C., Morrison, C., Jamison, J., Diehl, L.F., Murphy, T., Piantadosi, S., Seifter, E., Ambinder, R.F., Vogelsang, G. and Grever, M.R. (2000) "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies", Blood 96, 71-75.
- O'Brien, S.M., Kantarjian, H.M., Cortes, J., Berom, M., Koller, C.A., Giles, F.J., Lerner, S. and Keating, M. (2001) "Results of fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", J. Clin. Oncol. 19, 1414-1420.
- Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnuco, G., Astori, C., Corso, A., Brusamolino, E., Simoucini, L., Morra, E. and Bernasconi (1999) "Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is offective in pretreated low-grade non-Hodgkin's lymphoma", Ann. Oncol. 10, 59-64.
- Dimopoulos, M.A., Zervas, C., Zomas, A., Kiamouris, C., Viniou, N.A., Grigoraki, V., Karkantaris, C., Mitsouli, C., Gika, D., Christakis, J. and Anagnostopoulos, N. (2002) "Treatment of Waldenstrom's macroglobulinemia with rituximab", J. Clin. Oncol. 20, 2327-2333.
Treatment of Waldenstrom's Macroglobulinemia with the Combination of Fludarabine and Cyclophosphamide
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.